Benitec Biopharma Inc.
Change of auditor (8-K Item 4.01)
The company reported a change of its independent auditor in a Form 8-K (Item 4.01) filed on 30 Sep 2026. Auditor changes are often routine (rotation, cost, mergers), but can follow disagreements over accounting.
More details →Change of auditor (8-K Item 4.01)
The company reported a change of its independent auditor in a Form 8-K (Item 4.01) filed on 24 Sep 2026. Auditor changes are often routine (rotation, cost, mergers), but can follow disagreements over accounting.
More details →Benitec Biopharma Inc. — Overview & Financial Snapshot
Benitec Biopharma Inc. (NasdaqCM: BNTC) is a Healthcare company, ranked #3,951 of 6,775 companies globally and #1,838 of 4,000 in United States on PositoAI, with a Positivity Score of 20,096. Its market capitalisation is ₹2,904.08 Cr ($307.67M), P/E ratio is -9.0 and P/B ratio is 1.74. It has no active red flags (PosiRed) and 2 yellow flags (PosiYellow, 4/10 points): Change of auditor (8-K Item 4.01); Change of auditor (8-K Item 4.01).
For financial statements, ratio trends and score history, Go Deep →